Corrigendum to “Use of nintedanib in interstitial lung disease other than idiopathic pulmonary fibrosis: Much caution is warranted” [Pulm. Pharmacol. 66 (2021 Feb) 101987]

Publication date: Available online 6 March 2021Source: Pulmonary Pharmacology & TherapeuticsAuthor(s): Marco Mura
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research